Yield of Rare Variants Detected by Targeted Next-Generation Sequencing in a Cohort of Romanian Index Patients with Hypertrophic Cardiomyopathy
Authors:
- Miruna Mihaela MicheuMMMiruna Mihaela Micheu
- Nicoleta-Monica Popa-FoteaNPNicoleta-Monica Popa-Fotea
- Nicoleta OprescuNONicoleta Oprescu
- Stefan BogdanSBStefan Bogdan
- Monica DanMDMonica Dan
- Alexandru DeaconuADAlexandru Deaconu
- Lucian DorobantuLDLucian Dorobantu
- Oana Gheorghe-FroneaOGOana Gheorghe-Fronea
- Maria GreavuMGMaria Greavu
- Corneliu IorgulescuCICorneliu Iorgulescu
- Alexandru Scafa-UdristeASAlexandru Scafa-Udriste
- Razvan TiculescuRTRazvan Ticulescu
Open Access
- 7 December 2020
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 10 (12) , 1061
Abstract
Background: The aim of this study was to explore the rare variants in a cohort of Romanian index cases with hypertrophic cardiomyopathy (HCM). Methods: Forty-five unrelated probands with HCM were screened by targeted next generation sequencing (NGS) of 47 core and emerging genes connected with HCM. Results: We identified 95 variants with allele frequency < 0.1% in population databases. MYBPC3 and TTN had the largest number of rare variants (17 variants each). A definite genetic etiology was found in 6 probands (13.3%), while inconclusive results due to either known or novel variants were established in 31 cases (68.9%). All disease-causing variants were detected in sarcomeric genes (MYBPC3 and MYH7 with two cases each, and one case in TNNI3 and TPM1 respectively). Multiple variants were detected in 27 subjects (60%), but no proband carried more than one causal variant. Of note, almost half of the rare variants were novel. Conclusions: Herein we reported for the first time the rare variants identified in core and putative genes associated with HCM in a cohort of Romanian unrelated adult patients. The clinical significance of most detected variants is yet to be established, additional studies based on segregation analysis being required for definite classification.Keywords
This publication has 45 references indexed in Scilit:
- Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement From the American Heart AssociationCirculation: Genomic and Precision Medicine, 2020
- Exploring the Continuum of Hypertrophic Cardiomyopathy—From DNA to Clinical ExpressionMedicina, 2019
- Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy GenesCirculation: Genomic and Precision Medicine, 2019
- Hypertrophic CardiomyopathyJACC: Heart Failure, 2018
- Association of Racial/Ethnic Categories With the Ability of Genetic Tests to Detect a Cause of CardiomyopathyJAMA Cardiology, 2018
- Clinical and Mechanistic Insights Into the Genetics of CardiomyopathyJACC, 2016
- New Perspectives on the Prevalence of Hypertrophic CardiomyopathyJACC, 2015
- 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathyEuropean Heart Journal, 2014
- Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencingJournal of Medical Genetics, 2013
- Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseasesEuropean Heart Journal, 2007